{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T17:39:23Z","timestamp":1791567563970,"version":"4.3.4"},"reference-count":33,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2008,3,17]],"date-time":"2008-03-17T00:00:00Z","timestamp":1205712000000},"content-version":"vor","delay-in-days":5554,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[1993,1]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>OBJECTIVE The objective of this study was to investigate serial changes in the plasma concentration of inhibin in both the very early days of pregnancy following implantation and in late pregnancy. The timing of the changes in inhibin concentration relative to changes in the concentrations of other hormones of pregnancy was also investigated.<\/jats:p><jats:p>DESIGN Serial observations of the peripheral concentrations of inhibin and other hormones in two groups of healthy volunteers in (a) early pregnancy and (b) late pregnancy.<\/jats:p><jats:p>PATIENTS (a) Four healthy women recruited on cessation of contraception prior to conception. (b) Nine healthy women recruited at the antenatal clinic.<\/jats:p><jats:p>MEASUREMENTS In the early pregnancy subjects, the concentrations of inhibin, progesterone, oestradiol and hCG were measured in plasma samples obtained three times per week from day 8 to day 10 of each menstrual cycle until 11 weeks after the last menstrual period in the conception cycle. In the late pregnancy subjects, plasma samples were obtained at 4\u2010week intervals from 12 weeks until term.<\/jats:p><jats:p>RESULTS The concentration of inhibin, progesterone and oestradiol in conception cycles were similar to those in the preceding cycles until the mid\/ to late\u2010luteal phase of the cycle when hCG was first measurable. By day 12 of the luteal phase the concentration of inhibin was significantly higher in the pregnancy cycle than in the non\u2010pregnancy cycle (P &gt; 0.05) and progressively increased after the time of the missed menstrual period. The concentration of inhibin reached a peak (513.0 U\/I, CI 442.1\u2013595.3) by day 47 when the concentration of hCG was maximal. In early pregnancy the concentration of inhibin was correlated with that of hCG (<jats:italic>r<\/jats:italic>= 0.361; <jats:italic>P<\/jats:italic>&gt;0.01) as well as progesterone (<jats:italic>r<\/jats:italic>= 0.584, <jats:italic>P<\/jats:italic>&gt;0.001) and oestradiol (<jats:italic>r<\/jats:italic>= 0.602. <jats:italic>P<\/jats:italic>&gt;0.001). After 12 weeks there was no significant correlation between hCG and lnhibin although significant correlations persisted with progesterone (<jats:italic>r<\/jats:italic>= 0.553, <jats:italic>P<\/jats:italic>&gt;0.001) and oestradiol (<jats:italic>r<\/jats:italic>= 0.361, <jats:italic>P<\/jats:italic>&gt;0.01).<\/jats:p><jats:p>CONCLUSIONS The corpus luteum makes a significant contribution to the production of inhibin in early pregnancy while after 12 weeks the placenta is the major source.<\/jats:p>","DOI":"10.1111\/j.1365-2265.1993.tb00979.x","type":"journal-article","created":{"date-parts":[[2008,3,17]],"date-time":"2008-03-17T11:24:33Z","timestamp":1205753073000},"page":"101-107","source":"Crossref","is-referenced-by-count":23,"title":["The relationship between peripheral immunoactive inhibin, human chorionic gonadotrophin, oestradiol and progesterone during human pregnancy"],"prefix":"10.1111","volume":"38","author":[{"given":"S.","family":"Tovanabutra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. J.","family":"Illingworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. L.","family":"Ledger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. F.","family":"Glasier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. T.","family":"Baird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,3,17]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-71-1-133"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.115R021"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1981.tb01690.x"},{"key":"e_1_2_1_5_1","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/oxfordjournals.humrep.a136882","article-title":"A comparison of the effects on follicular development between clomiphene citrate, its two separate isomers and spontaneous cycles","volume":"4","author":"Glasier A.F.","year":"1989","journal-title":"Human Reproduction"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1990.tb00497.x"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-73-3-667"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1991.tb01730.x"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-73-6-1180"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(86)90758-8"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(16)59599-5"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1987.tb02949.x"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-68-6-1078"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/0303-7207(87)90162-6"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-71-5-1294"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.3299703"},{"key":"e_1_2_1_17_1","first-page":"5114","volume-title":"Inhibin and activin modulate the release of gonadotropin\u2010releasing hormone, human chorionic gonadotropin and progesterone from cultured human placental cells","author":"Petraglia F.","year":"1989"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-72-4-862"},{"key":"e_1_2_1_19_1","article-title":"Expression of inhibin alpha subunit mRNA in the human corpus luteum is maintained throughout the luteal phase","volume":"124","author":"Reddi K.","year":"1990","journal-title":"Journal of Endocrinology"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1210\/endo-128-6-3122"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1210\/endo-125-4-2141"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/0303-7207(88)90047-0"},{"key":"e_1_2_1_23_1","volume-title":"Lnhibin concentrations in ongoing and failing first trimester IVF pregnancies","author":"Rombauts L.","year":"1990"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.1260489"},{"key":"e_1_2_1_25_1","volume-title":"Local Regulation of Ovarian Function","author":"Smith K.B.","year":"1992"},{"key":"e_1_2_1_26_1","volume-title":"Serum inhibin during pregnancy in women without ovarian function","author":"Smitz J.","year":"1990"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(91)90536-Z"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(90)90445-K"},{"key":"e_1_2_1_29_1","article-title":"Immunoactivity and bioactivity of inhibin\u2010like substance in human placenta throughout pregnancy","volume":"126","author":"Tovanabutra S.","year":"1990","journal-title":"Journal of Endocrinology"},{"key":"e_1_2_1_30_1","article-title":"Immunolocalization of inhibin \u03b1\u2010and \u03b2\u2010subunits in human placental tissue at different stages of pregnancy","volume":"129","author":"Tovanabutra S.","year":"1991","journal-title":"Journal of Endocrinology"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.1100341"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/345732a0"},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.1280465"},{"key":"e_1_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1071\/RD9910671"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2265.1993.tb00979.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2265.1993.tb00979.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T00:32:28Z","timestamp":1698193948000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2265.1993.tb00979.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1993,1]]}},"alternative-id":["10.1111\/j.1365-2265.1993.tb00979.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2265.1993.tb00979.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,1]]}}}